The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

NCT05360615 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Empagliflozin in Post AKI Stage 2-3

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

Chulalongkorn University